Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Mental health and substance use associated with hospitalization among people with laboratory confirmed diagnosis of COVID-19 in British Columbia: a population-based cohort study

Héctor Alexander Velásquez García, James Wilton, Kate Smolina, Mei Chong, Drona Rasali, Michael Otterstatter, Caren Rose, Natalie Prystajecky, Samara David, Eleni Galanis, Geoffrey McKee, Mel Krajden, Naveed Zafar Janjua
doi: https://doi.org/10.1101/2021.08.26.21262697
Héctor Alexander Velásquez García
1British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
2School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Wilton
1British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
2School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kate Smolina
1British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
2School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mei Chong
1British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Drona Rasali
1British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
2School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Otterstatter
1British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
2School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caren Rose
1British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
2School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Natalie Prystajecky
1British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samara David
3Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eleni Galanis
1British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
2School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geoffrey McKee
1British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mel Krajden
1British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
4Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naveed Zafar Janjua
1British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada
2School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada
5Centre for Health Evaluation and Outcome Sciences, St Paul’s Hospital, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: naveed.janjua@bccdc.ca
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background This study identified factors associated with hospital admission among people with laboratory-diagnosed COVID-19 cases in British Columbia.

Methods This study was performed using the BC COVID-19 Cohort, which integrates data on all COVID-19 cases, hospitalizations, medical visits, emergency room visits, prescription drugs, chronic conditions and deaths. The analysis included all laboratory-diagnosed COVID-19 cases in British Columbia as of January 15th, 2021. We evaluated factors associated with hospital admission using multivariable Poisson regression analysis with robust error variance.

Findings From 56,874 COVID-19 cases included in the analyses, 2,298 were hospitalized. Models showed significant association of the following factors with increased hospitalization risk: male sex (adjusted risk ratio (aRR)=1.27; 95%CI=1.17-1.37), older age (p-trend <0.0001 across age groups with a graded increase in hospitalization risk with increasing age [aRR 30-39 years=3.06; 95%CI=2.32-4.03, to aRR 80+years=43.68; 95%CI=33.41-57.10 compared to 20-29 years-old]), asthma (aRR=1.15; 95%CI=1.04-1.26), cancer (aRR=1.19; 95%CI=1.09-1.29), chronic kidney disease (aRR=1.32; 95%CI=1.19-1.47), diabetes (treated without insulin aRR=1.13; 95%CI=1.03-1.25, requiring insulin aRR=5.05; 95%CI=4.43-5.76), hypertension (aRR=1.19; 95%CI=1.08-1.31), injection drug use (aRR=2.51; 95%CI=2.14-2.95), intellectual and developmental disabilities (aRR=1.67; 95%CI=1.05-2.66), problematic alcohol use (aRR=1.63; 95%CI=1.43-1.85), immunosuppression (aRR=1.29; 95%CI=1.09-1.53), and schizophrenia and psychotic disorders (aRR=1.49; 95%CI=1.23-1.82). Among women of reproductive age, in addition to age and comorbidities, pregnancy (aRR=2.69; 95%CI=1.42-5.07) was associated with increased risk of hospital admission.

Interpretation Older age, male sex, substance use, intellectual and developmental disability, chronic comorbidities, and pregnancy increase the risk of COVID-19-related hospitalization.

Funding BC Centre for Disease Control, Canadian Institutes of Health Research.

Evidence before this study Factors such as older age, social inequities and chronic health conditions have been associated to severe COVID-19 illness. Most of the evidence comes from studies that don’t include all COVID-19 diagnoses in a jurisdiction), focusing on in-hospital mortality. In addition, mental illness and substance use were not evaluated in these studies. This study assessed factors associated with hospital admission among people with laboratory-diagnosed COVID-19 cases in British Columbia.

Added value of this study In this population-based cohort study that included 56,874 laboratory-confirmed COVID-19 cases, older age, male sex, injection drug use, problematic alcohol use, intellectual and developmental disability, schizophrenia and psychotic disorders, chronic comorbidities and pregnancy were associated with the risk of hospitalization. Insulin-dependent diabetes was associated with higher risk of hospitalization, especially in the subpopulation younger than 40 years. To the best of our knowledge this is the first study reporting this finding, (insulin use and increased risk of COVID-19-related death has been described previously).

Implications of all the available evidence Prioritization of vaccination in population groups with the above mentioned risk factors could reduce COVID-19 serious outcomes. The findings indicate the presence of the syndemic of substance use, mental illness and COVID-19, which deserve special public health considerations.

Competing Interest Statement

MK has received grant funding via his institution from Roche Molecular Systems, Boehringer Ingelheim, Merck, Siemens Healthcare Diagnostics and Hologic Inc. All other authors have no potential conflicts of interest to declare.

Funding Statement

This work was supported by BC Centre for Disease Control and the Canadian Institutes of Health Research [Grant # VR5-172683 and OV4-170361]. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was reviewed and approved by the Behavioral Research Ethics Board at the University of British Columbia (approval # H20-02097).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The study is based on data contained in various provincial registries and databases. Access to data could be requested through the BC Centre for Disease Control Institutional Data Access for researchers who meet the criteria for access to confidential data. Requests for the data may be sent to datarequest{at}bccdc.ca.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 28, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Mental health and substance use associated with hospitalization among people with laboratory confirmed diagnosis of COVID-19 in British Columbia: a population-based cohort study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Mental health and substance use associated with hospitalization among people with laboratory confirmed diagnosis of COVID-19 in British Columbia: a population-based cohort study
Héctor Alexander Velásquez García, James Wilton, Kate Smolina, Mei Chong, Drona Rasali, Michael Otterstatter, Caren Rose, Natalie Prystajecky, Samara David, Eleni Galanis, Geoffrey McKee, Mel Krajden, Naveed Zafar Janjua
medRxiv 2021.08.26.21262697; doi: https://doi.org/10.1101/2021.08.26.21262697
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Mental health and substance use associated with hospitalization among people with laboratory confirmed diagnosis of COVID-19 in British Columbia: a population-based cohort study
Héctor Alexander Velásquez García, James Wilton, Kate Smolina, Mei Chong, Drona Rasali, Michael Otterstatter, Caren Rose, Natalie Prystajecky, Samara David, Eleni Galanis, Geoffrey McKee, Mel Krajden, Naveed Zafar Janjua
medRxiv 2021.08.26.21262697; doi: https://doi.org/10.1101/2021.08.26.21262697

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (239)
  • Allergy and Immunology (521)
  • Anesthesia (124)
  • Cardiovascular Medicine (1418)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (582)
  • Epidemiology (10288)
  • Forensic Medicine (6)
  • Gastroenterology (527)
  • Genetic and Genomic Medicine (2625)
  • Geriatric Medicine (254)
  • Health Economics (496)
  • Health Informatics (1729)
  • Health Policy (789)
  • Health Systems and Quality Improvement (671)
  • Hematology (266)
  • HIV/AIDS (564)
  • Infectious Diseases (except HIV/AIDS) (12083)
  • Intensive Care and Critical Care Medicine (648)
  • Medical Education (273)
  • Medical Ethics (83)
  • Nephrology (288)
  • Neurology (2456)
  • Nursing (144)
  • Nutrition (377)
  • Obstetrics and Gynecology (491)
  • Occupational and Environmental Health (566)
  • Oncology (1320)
  • Ophthalmology (400)
  • Orthopedics (146)
  • Otolaryngology (235)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (342)
  • Pediatrics (778)
  • Pharmacology and Therapeutics (329)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2395)
  • Public and Global Health (4999)
  • Radiology and Imaging (893)
  • Rehabilitation Medicine and Physical Therapy (525)
  • Respiratory Medicine (681)
  • Rheumatology (309)
  • Sexual and Reproductive Health (255)
  • Sports Medicine (244)
  • Surgery (297)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)